These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 17053291

  • 1. The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease.
    Tsuboi K, Ueshiba H, Shimojo M, Ishikawa M, Watanabe N, Nagasawa K, Yuasa R, Yoshino G.
    Endocr J; 2007 Feb; 54(1):39-43. PubMed ID: 17053291
    [Abstract] [Full Text] [Related]

  • 2. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.
    Takata K, Kubota S, Fukata S, Kudo T, Nishihara E, Ito M, Amino N, Miyauchi A.
    Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623
    [Abstract] [Full Text] [Related]

  • 3. Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil.
    Yoshimura Noh J, Inoue K, Suzuki N, Yoshihara A, Fukushita M, Matsumoto M, Imai H, Hiruma S, Ichikawa M, Koshibu M, Sankoda A, Hirose R, Watanabe N, Sugino K, Ito K.
    Endocr J; 2024 Jul 12; 71(7):695-703. PubMed ID: 38710619
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sudden onset agranulocytosis and hepatotoxicity after taking methimazole.
    Yang J, Zhong J, Zhou LZ, Hong T, Xiao XH, Wen GB.
    Intern Med; 2012 Jul 12; 51(16):2189-92. PubMed ID: 22892501
    [Abstract] [Full Text] [Related]

  • 13. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
    Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N.
    J Clin Endocrinol Metab; 2007 Jun 12; 92(6):2157-62. PubMed ID: 17389704
    [Abstract] [Full Text] [Related]

  • 14. A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment.
    Reinwein D, Benker G, Lazarus JH, Alexander WD.
    J Clin Endocrinol Metab; 1993 Jun 12; 76(6):1516-21. PubMed ID: 8501160
    [Abstract] [Full Text] [Related]

  • 15. Adverse effects related to thionamide drugs and their dose regimen.
    Werner MC, Romaldini JH, Bromberg N, Werner RS, Farah CS.
    Am J Med Sci; 1989 Apr 12; 297(4):216-9. PubMed ID: 2523194
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism.
    Homsanit M, Sriussadaporn S, Vannasaeng S, Peerapatdit T, Nitiyanant W, Vichayanrat A.
    Clin Endocrinol (Oxf); 2001 Mar 12; 54(3):385-90. PubMed ID: 11298092
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Change in serum G-CSF levels in patients with Graves' disease by treatment with methimazole].
    Hara H, Ban Y, Sato R, Ishikawa N, Yoshimura H, Hisaoka T, Ito K.
    Nihon Naibunpi Gakkai Zasshi; 1992 Oct 20; 68(10):1121-9. PubMed ID: 1281122
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.